Full Press Release Details
IDE196 Program Updates Targeting Initiation of Potentially Registration Enabling Phase 2 Single Arm Monotherapy Trial in MUM and Introduction of Tablet Formulation in Q1 2020.
IDYA
IDE196 Program Updates Targeting Initiation of Potentially Registration Enabling Phase 2 Single Arm Monotherapy Trial in MUM and Introduction of Tablet Formulation in Q1 2020
Key Takeaway: IDE196 Program Updates Targeting Initiation of Potentially Registration Enabling Phase 2 Single Arm Monotherapy Trial in MUM and Introduction of Tablet Formulation in Q1 2020